New study aims to find better treatment for stomach infection
NCT ID NCT07574983
First seen May 14, 2026 · Last updated May 16, 2026 · Updated 1 time
Summary
This study compares two 14-day antibiotic treatments for Helicobacter pylori, a stomach infection that can cause ulcers and cancer. 90 adults will be randomly assigned to receive either levofloxacin-based sequential therapy or bismuth-based quadruple therapy. The goal is to see which treatment works better and is safer, especially in areas with high antibiotic resistance.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HELICOBACTER PYLORI INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.